Home | PHARMAC
Home | PHARMAC
  • Website
  • Application Tracker
  • Schedule
  • About PHARMAC
    • About PHARMAC
    • Your guide to PHARMAC
    • Our history
    • Our people
    • Expert advice
    • PHARMAC's performance
    • Operating policies and procedures
    • Year in review 2018
    • Strategies
  • Medicines
    • Medicines
    • How medicines are funded
    • Medicines information
    • My medicine or medical device has changed
    • Your health
    • Hospital pharmaceuticals
    • New medicines – from development to funding
    • Equity
  • Hospital devices
    • Hospital devices
    • What's happening in each category?
    • PHARMAC's approach to hospital devices
    • Device Advice
    • PHARMAC medical devices forums 2017
  • News
  • Te Whaioranga
    • Te Whaioranga
    • Te Whaioranga 2013 - 2023: Māori Responsiveness Strategy
    • Whānau Ora
    • He Rongoā Pai, He Oranga Whānau
    • One Heart Many Lives
    • Scholarships
    • Hauora Arotahi - Māori health areas of focus
    • Māori Responsiveness Team
  • Pacific
    • Pacific
    • Pacific responsiveness strategy
    • Pacific action plan
  • Tools & resources
    • Tools & resources
    • Pharmaceutical Schedule
    • Annual Procurement Plan
    • Forms
    • Research
    • Print and PDF resources
    • Glossary
    • PHARMAC labelling preferences for prescription pharmaceuticals
  • Information for…
  1. About PHARMAC /
  2. Our history /
  3. Wise drug choices

See more about this section

About PHARMAC

  • Your guide to PHARMAC
  • Our history
    • Important events timeline
    • 25 year history - introduction from Sarah Fitt
    • A pressing need
    • Decision criteria
    • Getting the balance right
    • Cheap medicines, big impact
    • PHARMAC ruffles feathers
    • Reducing pressure
    • A watershed legal win
    • Wise drug choices
    • A mark of trust
    • Tackling health inequities head on
    • Hearing from the people who matter most
    • Saving money, saving lives
    • Decision making in the spotlight
    • Moving forward together
    • Hard choices
    • Special cases
    • Contributing to discussion, open to debate
    • No hospital pass
    • What could possibly go wrong?
    • From medicines to devices
    • All about people
    • The envy of nations
    • Trade winds
    • Challenges ahead
    • 25 years on – a secure legacy
  • Our people
  • Expert advice
  • PHARMAC's performance
  • Operating policies and procedures
  • Year in review 2018
  • Strategies

About PHARMAC

  • Your guide to PHARMAC
  • Our history
    • Important events timeline
    • 25 year history - introduction from Sarah Fitt
    • A pressing need
    • Decision criteria
    • Getting the balance right
    • Cheap medicines, big impact
    • PHARMAC ruffles feathers
    • Reducing pressure
    • A watershed legal win
    • Wise drug choices
    • A mark of trust
    • Tackling health inequities head on
    • Hearing from the people who matter most
    • Saving money, saving lives
    • Decision making in the spotlight
    • Moving forward together
    • Hard choices
    • Special cases
    • Contributing to discussion, open to debate
    • No hospital pass
    • What could possibly go wrong?
    • From medicines to devices
    • All about people
    • The envy of nations
    • Trade winds
    • Challenges ahead
    • 25 years on – a secure legacy
  • Our people
  • Expert advice
  • PHARMAC's performance
  • Operating policies and procedures
  • Year in review 2018
  • Strategies

Wise drug choices

While PHARMAC’s work in securing better prices for pharmaceuticals on behalf of New Zealanders was clearly paying off, the agency realised it also had to take a leadership role in advocating for better use of the pharmaceuticals it funded.

In 1998 it joined forces with the Independent Practice Associations and the Pharmacy Guild to tackle a growing issue of concern to health professionals – the misuse of antibiotics.

Antibiotics are used to attack potentially harmful bacteria, but as part of their normal defence against this attack the bacteria can become
‘used to’ or resistant to particular antibiotics.

That sees the antibiotics lose their effectiveness.

“It’s very easy to say with all these new infections, we just need new antibiotics. No, we make sure that the antibiotics we’ve got we use well,” says PHARMAC’s former medical director, Peter Moodie.

In 1998 the Ministry of Health sounded the alarm about growing antibiotics resistance, convening a national committee to look into the issue.

A particular area of concern was the overuse of antibiotics during the winter months, when doctors were prescribing them unnecessarily for patients with colds and influenza, which are viral infections. Those who were taking antibiotics often weren’t completing their prescribed regime, exacerbating the problem further.

“It is time to explode the myth that antibiotics are a cure-all for winter ailments. They are not,” said Prime Minister Jenny Shipley in May of 1999 as she launched the Wise Use of Antibiotics national campaign.

"The misuse of these drugs actually reduces their effectiveness, meaning people need increasingly potent and expensive antibiotics to cure simple ailments.”

The Prime Minister had put her finger on a key issue for PHARMAC, which spent tens of millions of dollars a year on purchasing antibiotics. If antibiotic resistance grew, the agency would need to fund increasingly expensive pharmaceuticals to treat a whole host of resulting health ailments.

PHARMAC took a leading role in what was to become an annual campaign that initially centred on doctor practices, with posters, leaflets and media coverage. Over the years, the Wise Use of Antibiotics broadened to appeal to the general public and crystalised around three key messages:

  • Antibiotics don’t do colds and flu.
  • Take the lot, no matter what.
  • If in doubt, check it out.

Advertisements aired on TV and radio and in newspapers and magazines.

“Do not deploy until you have identified your target!” shouts the stern general in front of his battle-ready battalion of antibiotics in the cartoon advert that aired through the winter of 2007.

“Antibiotics, never forget that bacteria are your only target! Cold and flu are viral, not bacterial infections. A virus is unaffected by antibiotics!”

The funding and other resources PHARMAC contributed to the campaign soon paid dividends. People got the message.

“Evidence from previous campaigns shows very high support for the
campaign by both clinicians and the public, with an overall reduction in antibiotic prescribing of nearly 14.8% (1999 compared with 2000 data), and a reduction in public expectation of receiving antibiotics for colds and flu from 80% to 50% (Colmar Brunton research),” noted PHARMAC’s 2001 Annual Review.

The Wise Use of Antibiotics campaign was to run annually for nearly two decades, with PHARMAC managing it for a decade, and its success informed other advocacy campaigns developed by PHARMAC over the years.

He Rongoā Pai – He Oranga Whānau began as a wānanga for hauora kaimahi who work in Māori communities. It is aimed at improving knowledge and providing information to whānau about the safe and effective use of medicines and includes a component on rongoā Māori.

The Space to Breathe childhood asthma pilot was developed to promote appropriate use of inhaled corticosteroids and self-management education to improve health outcomes for children with asthma and address ethnic disparities in morbidity.

Making a Difference in Dementia was a pilot programme based at two aged residential care facilities in the Wellington region. It explored methods to ensure antipsychotics were prescribed at the lowest effective dose, for the shortest possible time and only for the specific indications in which they had proven benefit.

“Over time we started to think more broadly about public health and pharmaceuticals and how we could help patients avoid having to take pharmaceuticals altogether,” says Wayne McNee, PHARMAC’s general manager at the time Wise Use of Antibiotics was launched.

These campaigns and pilot programmes would define PHARMAC as more than just a pharmaceutical management agency.

Last updated: 13 September 2018

Related info

1998

Decisions in the High Court and Court of Appeal and the Privy Council uphold PHARMAC’s procedures in pharmaceutical expenditure management, and its exemption from the Commerce Act.

Wayne McNee appointed General Manager of PHARMAC (November).


Wayne McNee

Wayne McNee

About this site

  • Sitemap
  • Copyright
  • Disclaimer
  • Privacy statement
  • This site is operated by PHARMAC, the Pharmaceutical Management Agency.

Contact

  • Contact us
  • Twitter - PHARMACnz
  • Facebook - PHARMACnz
  • YouTube - PHARMACgovtnz
  • LinkedIn - Pharmaceutical Management Agency (PHARMAC)
  • Careers
  • Newsfeed

Back to top

New Zealand Government